Physician profile
John Perl
NPI 1518906312
$19,290.54
in general payments reported to CMS, 2019-2025
11 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $131 · 2021: $34.54 · 2022: $781 · 2023: $452 · 2024: $945 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,851.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $16,837.44 | 2019-2025 | Target, Surpass Evolve, Mild Device Kit |
| Microvention, INC. | $661.14 | 2019-2025 | Web Aneurysm Embolization System, Stent |
| Medtronic, INC. | $574.19 | 2021-2025 | Solitaire X, Pipeline, Kyphon Express II Kyphopak Tray |
| Siemens Medical Solutions USA, INC. | $358.93 | 2020-2022 | |
| Qapel Medical INC | $283.48 | 2024 | |
| Depuy Synthes Sales INC. | $202.55 | 2019-2025 | Trufill |
| Penumbra, INC. | $159.75 | 2022-2025 | Penumbra System, Penumbra Coil 400 |
| Medtronic USA, INC. | $84.98 | 2019-2020 | |
| Insightec,INC | $83.58 | 2019 | |
| Abbott Laboratories | $44.50 | 2024-2025 | Xact |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$102,315.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Perl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.